Business

Announcement on Obtaining Notice of Approval for Re-Registration of Drug by Wholly-owned Subsidiary

Announcement on Obtaining Notice of Approval for Re-Registration of Drug by Wholly-owned Subsidiary

articleHangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class ADecember 18, 20255/news/announcement-on-obtaining-notice-of-approval-for-re-registration-of-drug-by-wholly-owned-subsidiary
Announcement on Obtaining Notice of Approval for Re-Registration of Drug by Wholly-owned Subsidiary

About this update from Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A

Announcement on Obtaining Notice of Approval for Re-Registration of Drug by Wholly-owned Subsidiary The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A